Cargando…
A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning
The immunophenotype is a key element to classify B-cell Non-Hodgkin Lymphomas (B-NHL); while it is routinely obtained through immunohistochemistry, the use of flow cytometry (FC) could bear several advantages. However, few FC laboratories can rely on a long-standing practical experience, and the lit...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352227/ https://www.ncbi.nlm.nih.gov/pubmed/32599959 http://dx.doi.org/10.3390/cancers12061684 |
_version_ | 1783557588513718272 |
---|---|
author | Gaidano, Valentina Tenace, Valerio Santoro, Nathalie Varvello, Silvia Cignetti, Alessandro Prato, Giuseppina Saglio, Giuseppe De Rosa, Giovanni Geuna, Massimo |
author_facet | Gaidano, Valentina Tenace, Valerio Santoro, Nathalie Varvello, Silvia Cignetti, Alessandro Prato, Giuseppina Saglio, Giuseppe De Rosa, Giovanni Geuna, Massimo |
author_sort | Gaidano, Valentina |
collection | PubMed |
description | The immunophenotype is a key element to classify B-cell Non-Hodgkin Lymphomas (B-NHL); while it is routinely obtained through immunohistochemistry, the use of flow cytometry (FC) could bear several advantages. However, few FC laboratories can rely on a long-standing practical experience, and the literature in support is still limited; as a result, the use of FC is generally restricted to the analysis of lymphomas with bone marrow or peripheral blood involvement. In this work, we applied machine learning to our database of 1465 B-NHL samples from different sources, building four artificial predictive systems which could classify B-NHL in up to nine of the most common clinico-pathological entities. Our best model shows an overall accuracy of 92.68%, a mean sensitivity of 88.54% and a mean specificity of 98.77%. Beyond the clinical applicability, our models demonstrate (i) the strong discriminatory power of MIB1 and Bcl2, whose integration in the predictive model significantly increased the performance of the algorithm; (ii) the potential usefulness of some non-canonical markers in categorizing B-NHL; and (iii) that FC markers should not be described as strictly positive or negative according to fixed thresholds, but they rather correlate with different B-NHL depending on their level of expression. |
format | Online Article Text |
id | pubmed-7352227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-73522272020-07-21 A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning Gaidano, Valentina Tenace, Valerio Santoro, Nathalie Varvello, Silvia Cignetti, Alessandro Prato, Giuseppina Saglio, Giuseppe De Rosa, Giovanni Geuna, Massimo Cancers (Basel) Article The immunophenotype is a key element to classify B-cell Non-Hodgkin Lymphomas (B-NHL); while it is routinely obtained through immunohistochemistry, the use of flow cytometry (FC) could bear several advantages. However, few FC laboratories can rely on a long-standing practical experience, and the literature in support is still limited; as a result, the use of FC is generally restricted to the analysis of lymphomas with bone marrow or peripheral blood involvement. In this work, we applied machine learning to our database of 1465 B-NHL samples from different sources, building four artificial predictive systems which could classify B-NHL in up to nine of the most common clinico-pathological entities. Our best model shows an overall accuracy of 92.68%, a mean sensitivity of 88.54% and a mean specificity of 98.77%. Beyond the clinical applicability, our models demonstrate (i) the strong discriminatory power of MIB1 and Bcl2, whose integration in the predictive model significantly increased the performance of the algorithm; (ii) the potential usefulness of some non-canonical markers in categorizing B-NHL; and (iii) that FC markers should not be described as strictly positive or negative according to fixed thresholds, but they rather correlate with different B-NHL depending on their level of expression. MDPI 2020-06-24 /pmc/articles/PMC7352227/ /pubmed/32599959 http://dx.doi.org/10.3390/cancers12061684 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Gaidano, Valentina Tenace, Valerio Santoro, Nathalie Varvello, Silvia Cignetti, Alessandro Prato, Giuseppina Saglio, Giuseppe De Rosa, Giovanni Geuna, Massimo A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title | A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title_full | A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title_fullStr | A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title_full_unstemmed | A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title_short | A Clinically Applicable Approach to the Classification of B-Cell Non-Hodgkin Lymphomas with Flow Cytometry and Machine Learning |
title_sort | clinically applicable approach to the classification of b-cell non-hodgkin lymphomas with flow cytometry and machine learning |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352227/ https://www.ncbi.nlm.nih.gov/pubmed/32599959 http://dx.doi.org/10.3390/cancers12061684 |
work_keys_str_mv | AT gaidanovalentina aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT tenacevalerio aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT santoronathalie aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT varvellosilvia aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT cignettialessandro aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT pratogiuseppina aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT sagliogiuseppe aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT derosagiovanni aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT geunamassimo aclinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT gaidanovalentina clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT tenacevalerio clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT santoronathalie clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT varvellosilvia clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT cignettialessandro clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT pratogiuseppina clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT sagliogiuseppe clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT derosagiovanni clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning AT geunamassimo clinicallyapplicableapproachtotheclassificationofbcellnonhodgkinlymphomaswithflowcytometryandmachinelearning |